It is clear that there are many impediments to properly informing policy and public education of which are necessary to address in the current landscape of increasing cannabis legalization and prevalence. Two of the main, overarching barriers include 1) the perception that cannabis is a single drug with “only good” or “only bad” outcomes and 2) the notion that cannabis is a form of alternative medicine. This manuscript does not aim to discredit or discount the therapeutic potential that cannabis may have; however, most studies that describe these benefits are analyzing distinct, isolated compounds, such as pure CBD, for example, as well as specific dosing schedules and routes of administration. The current evidence suggests more harms associated with cannabis use in mental illness than benefits; however, these studies are mostly observational and reflect recreational cannabis, which contains increasingly higher THC potency and lower CBD concentrations [47]. With this said, cannabis is a drug of many constituents with differential effects, which can be combined and prepared in various forms, placing it in what Hill describes as a ‘gray zone’ that is
